Alnylam Pharmaceuticals
ALNY
#545
Rank
$45.28 B
Marketcap
$339.41
Share price
1.92%
Change (1 day)
41.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company